What do systematic reviews say?

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 411 participants
  Low

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 35 participants
  Low

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 131 participants
  Moderate

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 426 participants
  Moderate

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 58 participants
  Low

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 40 participants
  Low

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 97 participants
  Moderate

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 280 participants
  Moderate

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 43 participants
  Low

Intervention not reported

• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 26 participants
  Moderate

Anti‐IgE mAb (omalizumab) vs usual care

Omalizumab probably leads to lower exacerbations compared with usual care (moderate certainty).

• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.48 [0.25, 0.92]
  1 study · 348 participants
  Moderate
• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.37 [0.17, 0.81]
  1 study · 184 participants
  Moderate
• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.63 [0.22, 1.79]
  1 study · 164 participants
  Moderate

Anti‐IgE mAb (omalizumab) vs usual care

Omalizumab showed no clear difference in adverse events compared with usual care (moderate certainty).

• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.99 [0.61, 1.58]
  1 study · 361 participants
  Moderate

A boost of inhaled corticosteroids vs usual care

A boost of inhaled corticosteroids showed no clear difference in exacerbations compared with usual care (moderate certainty).

• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.86 [0.32, 2.3]
  1 study · 173 participants
  Moderate

A boost of inhaled corticosteroids vs usual care

A boost of inhaled corticosteroids showed no clear difference in adverse events compared with usual care (moderate certainty).

• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.67 [0.34, 1.33]
  1 study · 176 participants
  Moderate

Leukotriene receptor antagonist vs usual care

The review found no eligible studies for this question.

• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.5 [0.17, 1.46]
  2 studies · 1326 participants
  Low

Leukotriene receptor antagonist vs usual care

Leukotriene receptor antagonist showed no clear difference in adverse events compared with usual care (high certainty).

• Interventions for autumn exacerbations of asthma in children 2018 · Cochrane Headline outcomes only
  OR 0.91 [0.63, 1.32]
  2 studies · 1326 participants
  High

Smart technology vs face‐to‐face/digital and/or written support

• Computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 239 participants
  Low

Smart technology vs face‐to‐face/digital and/or written support

• Computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 239 participants
  Low

Smart technology vs face‐to‐face/digital and/or written support

• Computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 472 participants
  Low

Smart technology vs face‐to‐face/digital and/or written support

• Computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 230 participants
  Low